Osteoporosis. Clinical guideline for prevention and treatment (Updated March 2013)
The National Osteoporosis Guideline Group have updated their guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK. This update incorporates a number of advances in the field including the Treatment of glucocorticoid-induced osteoporosis and Duration and monitoring of bisphosphonate therapy.
The updated guidance is supported by The National Osteoporosis Society and is available from www.shef.ac.uk/NOGG
Oral Health Management of Patients Prescribed Bisphosphonates (published April 2011)
This guidance has been developed by the Scottish Dental Clinical Effectiveness Programme (SDCEP). It provides clear and practical advice for dentists in primary care on how to provide care for patients prescribed bisphosphonates. The guidance is also of relevance to prescribers and dispensers of bisphosphonates and to patients.
Guidance for the Management of Breast Cancer Treatment-Induced Bone Loss: A consensus position statement from a UK Expert Group
Reviewed and supported by the National Osteoporosis Society, the National Cancer Research Institute, Breast Cancer Study Group and the International Osteoporosis Foundation.
A group of UK experts have drawn up a guidance report for the management of breast-cancer induced bone loss. The new report, which was created after a full review of available literature, has been endorsed by The National Osteoporosis Society. The full guidance document and two treatment algorithms, one for premenopausal women and one for postmenopausal women, is available here.
Royal College of Physicians Glucocorticoid guidelines 2002
You can also download the guidelines from the Royal College of Physicians on Glucocorticoids by using the links below: